Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $23.5300 (2.39%) ($22.5500 - $24.0000) on Mon. Nov. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.2% (three month average) | RSI | 90 | Latest Price | $23.5300(2.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 3.8% a day on average for past five trading days. | Weekly Trend | ATRA advances 26.3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(46%) ARKK(45%) IBB(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -2.1% in a week (0% probabilities). VIXM(-33%) VXX(-26%) UNG(-11%) UUP(-9%) TLT(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.1% (StdDev 4.2%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $22(6.95%) | 10 Day Moving Average | $19.87(18.42%) | 20 Day Moving Average | $16.86(39.56%) | To recent high | 0% | To recent low | 87.5% | Market Cap | $1.748b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |